chr2-166061933-T-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001165963.4(SCN1A):​c.265-3245A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.206 in 152,106 control chromosomes in the GnomAD database, including 3,495 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.21 ( 3495 hom., cov: 33)

Consequence

SCN1A
NM_001165963.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0340

Publications

1 publications found
Variant links:
Genes affected
SCN1A (HGNC:10585): (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.351 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001165963.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1A
NM_001165963.4
MANE Select
c.265-3245A>T
intron
N/ANP_001159435.1
SCN1A
NM_001202435.3
c.265-3245A>T
intron
N/ANP_001189364.1
SCN1A
NM_001353948.2
c.265-3245A>T
intron
N/ANP_001340877.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1A
ENST00000674923.1
MANE Select
c.265-3245A>T
intron
N/AENSP00000501589.1
SCN1A
ENST00000303395.9
TSL:5
c.265-3245A>T
intron
N/AENSP00000303540.4
SCN1A
ENST00000375405.7
TSL:5
c.265-3245A>T
intron
N/AENSP00000364554.3

Frequencies

GnomAD3 genomes
AF:
0.206
AC:
31377
AN:
151988
Hom.:
3494
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.164
Gnomad AMI
AF:
0.232
Gnomad AMR
AF:
0.244
Gnomad ASJ
AF:
0.165
Gnomad EAS
AF:
0.365
Gnomad SAS
AF:
0.279
Gnomad FIN
AF:
0.237
Gnomad MID
AF:
0.199
Gnomad NFE
AF:
0.205
Gnomad OTH
AF:
0.183
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.206
AC:
31389
AN:
152106
Hom.:
3495
Cov.:
33
AF XY:
0.211
AC XY:
15683
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.164
AC:
6798
AN:
41536
American (AMR)
AF:
0.244
AC:
3734
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.165
AC:
572
AN:
3468
East Asian (EAS)
AF:
0.365
AC:
1885
AN:
5164
South Asian (SAS)
AF:
0.278
AC:
1340
AN:
4818
European-Finnish (FIN)
AF:
0.237
AC:
2511
AN:
10588
Middle Eastern (MID)
AF:
0.197
AC:
58
AN:
294
European-Non Finnish (NFE)
AF:
0.205
AC:
13898
AN:
67944
Other (OTH)
AF:
0.181
AC:
382
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1285
2571
3856
5142
6427
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
344
688
1032
1376
1720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.212
Hom.:
435
Bravo
AF:
0.201
Asia WGS
AF:
0.296
AC:
1030
AN:
3472

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
1.3
DANN
Benign
0.48
PhyloP100
-0.034
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2892992; hg19: chr2-166918443; API